Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis
Jasmine C Wong,
Kelley M Weinfurtner,
Maria del pilar Alzamora,
Scott C Kogan,
Michael R Burgess,
Yan Zhang,
Joy Nakitandwe,
Jing Ma,
Jinjun Cheng,
Shann-Ching Chen,
Theodore T Ho,
Johanna Flach,
Damien Reynaud,
Emmanuelle Passegué,
James R Downing,
Kevin Shannon
Affiliations
Jasmine C Wong
Department of Pediatrics, University of California, San Francisco, San Francisco, United States
Kelley M Weinfurtner
Department of Pediatrics, University of California, San Francisco, San Francisco, United States
Maria del pilar Alzamora
Department of Pediatrics, University of California, San Francisco, San Francisco, United States
Scott C Kogan
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, United States
Michael R Burgess
Division of Hematology/Oncology, University of California, San Francisco, San Francisco, United States
Yan Zhang
Unit of Hematopoietic Stem Cell and Transgenic Animal Models, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China
Joy Nakitandwe
Department of Pathology, St. Jude Children's Research Hospital, Memphis, United States
Jing Ma
Department of Pathology, St. Jude Children's Research Hospital, Memphis, United States
Jinjun Cheng
Department of Pathology, St. Jude Children's Research Hospital, Memphis, United States
Shann-Ching Chen
Department of Pathology, St. Jude Children's Research Hospital, Memphis, United States
Theodore T Ho
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, University of California, San Francisco, San Francisco, United States
Johanna Flach
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, University of California, San Francisco, San Francisco, United States
Damien Reynaud
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, University of California, San Francisco, San Francisco, United States
Emmanuelle Passegué
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, University of California, San Francisco, San Francisco, United States
James R Downing
Department of Pathology, St. Jude Children's Research Hospital, Memphis, United States
Kevin Shannon
Department of Pediatrics, University of California, San Francisco, San Francisco, United States
Chromosome 7 deletions are highly prevalent in myelodysplastic syndrome (MDS) and likely contribute to aberrant growth through haploinsufficiency. We generated mice with a heterozygous germ line deletion of a 2-Mb interval of chromosome band 5A3 syntenic to a commonly deleted segment of human 7q22 and show that mutant hematopoietic cells exhibit cardinal features of MDS. Specifically, the long-term hematopoietic stem cell (HSC) compartment is expanded in 5A3+/del mice, and the distribution of myeloid progenitors is altered. 5A3+/del HSCs are defective for lymphoid repopulating potential and show a myeloid lineage output bias. These cell autonomous abnormalities are exacerbated by physiologic aging and upon serial transplantation. The 5A3 deletion partially rescues defective repopulation in Gata2 mutant mice. 5A3+/del hematopoietic cells exhibit decreased expression of oxidative phosphorylation genes, increased levels of reactive oxygen species, and perturbed oxygen consumption. These studies provide the first functional data linking 7q22 deletions to MDS pathogenesis.